In This Section

Program

Please note that this meeting will take place as an in-person event in Calgary, Alberta, Canada and will not live-stream content for virtual participation.

Tuesday, July 20

Wednesday, July 21

THURSDAY, JULY 22

Tuesday, July 20

REGISTRATION

3-9 p.m.

WELCOME AND OPENING Keynote

5-5:40 p.m.

  • 5:05 p.m. | Keynote Lecture
    Kathleen Burns, Dana-Farber Cancer Institute, Boston, Massachusetts

Plenary Session 1: Title to be Announced

Organized by the Pathology in Cancer Research Working Group (PICR)

5:40-7 p.m.

Opening Reception/ Poster Session A

7-8:30 p.m.

Wednesday, July 21

Breakfast with Career Development Roundtables and Ask a Pathologist

7-8 a.m.

Plenary Session 2: The Evolving Landscape of Pathology in Cancer Research

8-9:20 a.m.

  • 8:05 a.m. | P.J. Van Diest, UMC Utrecht, Utrecht, Netherlands
  • 8:30 a.m. | Sarah Hill, Dana-Farber Cancer Institute, Boston, Massachusetts
  • 8:55 a.m. | Spatial profiling of bioengineered tumor microenvironments: benchmarking in vitro fidelity for immuno-oncology
    Lauriane Cabon, Roche Pharma Ltd., Kanton Reinach, Switzerland

Additional speakers to be announced

Break

9:20-9:50 a.m.

Plenary Session 3: Digital Pathology and AI – Revolutionizing Cancer Diagnostics

9:50-11:10 a.m.

  • 9:55 a.m. | Andrew Beck, Roche, Boston, Massachusetts
  • 10:20 a.m. | Foundation models in pathology AI
  • Andrew H. Song, The University of Texas MD Anderson Cancer Center, Houston, Texas

Additional speakers to be announced

Spotlight on Highly Rated Abstracts

11:10 a.m-12:10 p.m.

Lunch on Own


12:10–1:50 p.m.

Plenary Session 4: Spatial Biology

2-3:45 p.m.

  • 2:20 p.m. | Lisa McGinnis, Genentech, Inc., South San Francisco, California
  • 2:45 p.m. | Shawn Davidson, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Additional speakers to be announced

break

3:10-3:30 p.m.

Plenary Session 5: Laboratory Pathology CAR-T/Liquid Biopsies – A Non-Invasive Frontier in Cancer Management

3:30-4:50 p.m.

  • 3:35 p.m. | Engineering and optimizing chimeric antigen receptor T cell therapies for genitourinary malignancies
    John Lee, University of California, Los Angeles, Los Angeles, California
  • 4:25 p.m. | Liquid biopsies for detecting response to intervention
    Nickolas Papadopoulos, Johns Hopkins University, Baltimore, Maryland

Additional speakers to be announced

Break

4:50-5:10 p.m.

Plenary Session 6: Companion Diagnostics and Biomarkers in Precision Oncology – From Discovery to Clinical Application

5:10-6:30 p.m.

  • 5:15p.m. | Gabriel Bien-Willner, Palmetto GBA LLC, Columbia, South Carolina
  • 5:40-6 p.m. | Principles of tissue-based biomarker validation for discovery, pathogenesis research and diagnostics
    Angelo De Marzo, Johns Hopkins University, Baltimore, Maryland

Additional speakers to be announced

Poster Session B / Reception

6:30-8 p.m.

Thursday, July 22

Breakfast with Career Development Roundtables and Ask a Pathologist

7-8 a.m.

Plenary Session 7: Pathological Evaluation of Treatment Response and Resistance

8-9:20 a.m.

  • 8:30 a.m. | Pathological evaluation of treatment response and resistance in NSCLC
  • Mari Mino-Kenudson, Massachusetts General Hospital, Boston, Massachusetts
  • 8:55 a.m. | Jorge Reis-Filho, Foresite Labs, San Francisco, California

Keynote

9:20-9:55 a.m.

Break

10-10:30 a.m.

Plenary Session 8: Multi-Omics Integration: A Holistic View of Cancer Biology 

10:30 a.m.- 12:15 p.m.

  • 10:35 a.m. | Mala Shanmugam, Emory Winship Cancer Institute, Atlanta, Georgia
  • 11 a.m. | Spatial and dynamic imaging of lipid metabolism in prostate cancer
    Lisa M. Butler, Adelaide University, Adelaide, South Australia, Australia
  • 11:25 a.m. | Rong Fan, Yale University School of Engineering and Applied Sciences, New Haven, Connecticut

Closing Remarks & Departure

11:50 a.m.